Until we hear anything official we should all just relax and go on leading our lives. Having a look at their website, they are still promoting HSC on their main home page, investor page and their business opportunity page. We should all know whats happening in the next few months anyways. My guess is that the patent case was the main reason why everything was delayed for such a long time. For a small company such a case could have killed them so it was no use pushing ahead if you don't have any clarity.
Well put! And refreshing too :)
P.S **** you dorkins
09-09-2011 02:35 PM
LFC
Yer dorkins is an arrogant knobhead, even Spencer thinks he's a physco
Go away dorkins - no one wants you here and you know nothing!
09-11-2011 01:02 PM
UK_
Hi Guys! Been on holiday for a while..
Did I miss anything?
09-11-2011 01:38 PM
Jundam
Just bitter people bickering with less bitter people. The only news worth taking in that you might have missed is the Replicel interview.
On a funny note; People are now using tit-growing cream on their heads as a result of the research that Yale published recently.
09-11-2011 02:15 PM
krewel
Quote:
Originally Posted by Jundam
On a funny note; People are now using tit-growing cream on their heads as a result of the research that Yale published recently.
One of those guys, that google their symptoms when being sick. Wikipedia seems to replace medschool haha
I sent an email to Dr. Gail Naughton around 3 weeks ago, asking if the trials were in progress and up to date. I made it clear that I was not expecting any results at this point and just wanted to know if they started trials. I'm not sure what to make of her reply but at least it seems Histogen is still alive ha.
Hi, CVAZBAR
Good to hear from you.
As I write this my clinical director and I are on our way to Alaska for the International Society of Hair Restoration Surgery annual meeting where our two year follow up hair study and some new applications of our product will be presented by both Dr. Craig Ziering and Dr. Neil Sadick. Our IND is under review in Asia and we are finalizing our regulatory strategy for North America. We will send out a formal statement shortly and remain excited by the level of interest in HSC from both clinicians and patients.
Please stay in touch.
Take care,
Gail
09-14-2011 07:20 PM
Penny Stock
IND =Investigational New Drug Application
Clinical Trials--Drug studies in humans can begin only after an IND is reviewed by the FDA and a local institutional review board (IRB). The board is a panel of scientists and non-scientists in hospitals and research institutions that oversees clinical research.